Oncorus, Inc. Contracts & Agreements
43 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (1)
- Human Resources (13)
- Intellectual Property (7)
- Real Estate (6)
- Uncategorized (7)
- Plan of Dissolution of Oncorus, Inc (Filed With SEC on June 7, 2023)
- Third Amendment to Lease Agreement by and between the Registrant and IQHQ-4 Corporate, LLC, dated September 26, 2022 (Filed With SEC on November 2, 2022)
- Second Amendment to Lease, dated September 13, 2022 (Filed With SEC on September 14, 2022)
- Employment Agreement by and between the registrant and Richard Wanstall, dated as of May 10, 2022 (Filed With SEC on August 4, 2022)
- Warrant to Purchase Shares of Common Stock by and between Oncorus, Inc. and K2 HealthVentures LLC, dated April 1, 2022 (Filed With SEC on April 5, 2022)
- Loan and Security Agreement, by and among Oncorus, Inc., K2 HealthVentures LLC and Ankura Trust Company, LLC, dated April 1, 2022 (Filed With SEC on April 5, 2022)
- Letter Agreement by and between the registrant and Mitchell Finer, Ph.D., dated as of January 25, 2022 (Filed With SEC on March 9, 2022)
- License Agreement by and between the registrant and Gaeta Therapeutics, Ltd., dated as of November 10, 2021 (Filed With SEC on March 9, 2022)
- Second Amendment to Lease Agreement by and between IQHQ-4 Corporate, LLC and the registrant, dated as of November 17, 2021 (Filed With SEC on March 9, 2022)
- Open Market Sale AgreementSM dated November 19, 2021, by and between Oncorus, Inc. and Jefferies LLC (Filed With SEC on November 19, 2021)
- Amended and Restated First Amendment to Lease Agreement by and between IQHQ-4 Corporate, LLC and the Registrant, dated as of October 25, 2021 (Filed With SEC on November 3, 2021)
- Description of Registrants Securities (Filed With SEC on March 10, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 9, 2021)
- Employment Agreement by and between the registrant and Steve Harbin, dated as of December 7, 2020 (Filed With SEC on February 9, 2021)
- Lease Agreement by and between IQHQ-4 Corporate, LLC and the Company, dated as of December 29, 2020 (Filed With SEC on February 9, 2021)
- 2020 Equity Incentive Plan (Filed With SEC on November 12, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on November 12, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 28, 2020)
- Form of Common Stock Certificate (Filed With SEC on September 28, 2020)
- 2020 Equity Incentive Plan (Filed With SEC on September 28, 2020)
- Form of Stock Option Grant Notice and Option Agreement for the 2020 Equity Incentive Plan (Filed With SEC on September 28, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on September 28, 2020)
- Amended and Restated Employment Agreement by and between the registrant and Theodore (Ted) Ashburn, M.D., PhD., to be in effect upon the closing of this offering (Filed With SEC on September 28, 2020)
- Amended and Restated Employment Agreement by and between the registrant and John P. McCabe, to be in effect upon the closing of this offering (Filed With SEC on September 28, 2020)
- Employment Agreement by and between the registrant and Christophe Quva, to be in effect upon the closing of this offering (Filed With SEC on September 28, 2020)
- Third Amended and Restated Investors Rights Agreement by and among the registrant and certain of its stockholders, dated as of August 5, 2019, as amended November 18, 2019 (Filed With SEC on September 11, 2020)
- Form of Common Stock Warrant Agreement (Filed With SEC on September 11, 2020)
- Form of Indemnification Agreement between the registrant and its directors and officers (Filed With SEC on September 11, 2020)
- 2016 Equity Incentive Plan, as amended (Filed With SEC on September 11, 2020)
- Form of Stock Option Grant Notice and Option Agreement for the 2016 Equity Incentive Plan, as amended (Filed With SEC on September 11, 2020)
- Form of Restricted Stock Grant Notice and Restricted Stock Agreement for the 2016 Equity Incentive Plan, as amended (Filed With SEC on September 11, 2020)
- Employment Agreement by and between the registrant and Theodore (Ted) Ashburn, M.D., PhD., dated as of July 16, 2018, as amended November 14, 2018 and April 6, 2020 (Filed With SEC on September 11, 2020)
- Offer Letter by and between the registrant and John P. McCabe, dated as of July 25, 2019, as amended April 6, 2020 (Filed With SEC on September 11, 2020)
- Offer Letter by and between the registrant and Christophe Quva, dated as of August 23, 2017 (Filed With SEC on September 11, 2020)
- Amended and Restated Employment Agreement by and between the registrant and Mitchell Finer, dated as of August 8, 2018, as amended November 14, 2018 and April 6, 2020 (Filed With SEC on September 11, 2020)
- License Agreement by and between the registrant, Ospedale San Raffaele S.r.l. and Fondazione Telethon, dated as of December 22, 2015, as amended June 30, 2017 (Filed With SEC on September 11, 2020)
- Exclusive License Agreement by and between the registrant and the University of Pittsburgh, dated as of March 23, 2016, as amended June 30, 2016, November 4, 2016 and October 29,... (Filed With SEC on September 11, 2020)
- Biomaterials License Agreement by and between the registrant and the University of Pittsburgh, dated as of September 28, 2016 (Filed With SEC on September 11, 2020)
- Non-Exclusive License Agreement by and between the registrant and The Washington University, dated as of July 7, 2016 (Filed With SEC on September 11, 2020)
- License Agreement by and between the registrant and Northwestern University, dated as of December 11, 2018, amended as of September 26, 2019 (Filed With SEC on September 11, 2020)
- License Agreement by and between the registrant and WuXi Biologics Ireland Limited, dated as of July 25, 2019 (Filed With SEC on September 11, 2020)
- Royalty Transfer Agreement by and among the registrant, MPM Foundation and UBS Foundation, dated as of March 31, 2016 (Filed With SEC on September 11, 2020)
- Hampshire Street Lease by and between the registrant and BMR-Hampshire LLC, dated as of May 10, 2016, as amended November 17, 2016 (Filed With SEC on September 11, 2020)
